Ivan Trifunovich - WaferGen Bio Insider

WGBS -- USA Stock  

USD 6.90  0.00  0.00%

Dr. Ivan D. Trifunovich, Ph.D., is Executive Chairman of the Board of WaferGen Biosystems Inc. Dr. Trifunovich has served as our Chief Executive Officer, President and director since March 2012. Dr. Trifunovich served as President, Chief Executive Officer and Chairman of the Board of Helicos BioSciences Corporationrationration1 from October 2010 to September 2012. Since August 2008, Dr. Trifunovich has served as a strategic consultant to global companies in the life sciences industry. Previously, Dr. Trifunovich served as the Senior Vice President of Third Wave Technologies, Inc., a molecular diagnostics company, from December 2001 through August 2008. Prior to joining Third Wave Technologies, Inc., Dr. Trifunovich held successive positions as Vice President of eBusiness and Vice President of Research Strategy and Operations at Pharmacia Corporationration Prior to joining Pharmacia, Dr. Trifunovich was a Director of New Product Marketing at Johnson Johnson, Inc. He began his career at BristolMyers Squibb, Inc. as a bench scientist, where he held several positions of increasing responsibility
Age: 51  Chairman Since 2015  Ph.D    
510-651-4450  http://www.wafergen.com
Trifunovich received his Ph.D. in organic. .

Ivan Trifunovich Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (90.11) % which means that it has lost $90.11 on every $100 spent on asset. This is way below average.
The company currently holds 2.94 M in liabilities with Debt to Equity (D/E) ratio of 0.8 which is about average as compared to similar companies. WaferGen Bio systems has Current Ratio of 1.78 which is within standard range for the sector.

Similar Executives

Entity Summary

WaferGen Biosystems, Inc. develops, manufactures, and sells systems for singlecell analysis and clinical research in the United States, Canada, Europe, and the Asia Pacific. WaferGen Bio systems (WGBS) is traded on Nasdaq Capital Markets in USA. It is located in WaferGen Biosystems, Inc.Fremont, CA and employs 55 people.

WaferGen Bio systems Leadership Team

Makoto Kaneshiro, Independent Director
Robert Schueren, Director
Joel Kanter, Lead Independent Director
William McKenzie, Director
Michael Henighan, CFO, Secretary and Treasurer
Rolland Carlson, CEO and President and Director
Raymond Hautamaki, Independent Director
Ivan Trifunovich, Executive Chairman

Stock Performance Indicators

Current Sentiment - WGBS

WaferGen Bio systems Investor Sentiment
Most of Macroaxis users are at this time bullish on WaferGen Bio systems. What is your outlook on investing in WaferGen Bio systems? Are you bullish or bearish?
98% Bullish
2% Bearish

Also Currentnly Active

Purchased over 20 shares of
2 days ago
Traded for 106.27
Purchased over 200 shares of
2 days ago
Traded for 10.56
Purchased over 70 shares of
2 days ago
Traded for 39.4
See also Your Current Watchlist. Please also try Bollinger Bands module to use bollinger bands indicator to analyze target price for a given investing horizon.